The U.S. government has agreed to purchase 1.4 million more courses of molnupiravir, Merck’s experimental COVID-19 antiviral drug, for roughly $1 billion, the drugmaker said Nov. 9. The deal is ...

The first pill shown to treat COVID-19 has moved one step closer to being available to the public. The pharmaceutical company Merck requested FDA emergency authorization Monday for their COVID-19 ...

NEW YORK (WABC) -- With two new pills now authorized by the FDA to fight the effects of COVID, there's a push for New York state to be first in line for the initial shipments. Supplies of Pfizer's ...

The FDA said Friday that Merck's anti-COVID-19 pill is effective in treating the virus but said that regulators will meet next week to investigate whether the pill is safe for people who are pregnant ...

The antiviral pill can be taken at home. More countries will have access to Merck & Co’s COVID-19 pill. The deal backed by the United Nations will allow nearly 30 drugmakers in Asia, Africa and the ...

WASHINGTON (AP) — A panel of U.S. health advisers on Tuesday narrowly backed the benefits of a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug ...

Pharmaceutical company Merck announced Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus. The company said it ...